Selinexor 80 MG Oral Tablet — RxCUI 2730152
RxNorm drug concept · Semantic clinical drug
RxCUI 2730152
Semantic clinical drug · SCD
● Current RxNorm concept 6 FDA products
9 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI2730152
Official nameSelinexor 80 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped6
Package NDCs mapped9
Reported Medicaid activity (SDUD)22 prescriptions · 1 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Selinexor: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Xpovio is a type of targeted cancer medicine called a nuclear export inhibitor. It works differently from most other myeloma treatments — it blocks a protein that cancer cells use...
- What exactly is Xpovio and why has my doctor prescribed it for my multiple myeloma?
- Swallow the tablet whole with a full glass of water — don't break, crush, or chew it. Take it at roughly the same time on each scheduled day. The good news is that food doesn't rea...
- When and how should I take my Xpovio tablets?
🕸️ Concept Web — How Selinexor 80 MG Oral Tablet Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Selinexor 80 MG Oral Tablet
RxCUI 2730152 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Selinexor
2178390IN
-
Selinexor
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Xpovio
2178397BN
-
Xpovio
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Selinexor Oral Tablet
2178394SCDF -
Selinexor Oral Product
2178392SCDG -
Selinexor Pill
2178393SCDG -
Selinexor Oral Tablet [Xpovio]
2178399SBDF -
Xpovio Oral Product
2178400SBDG -
Xpovio Pill
2178401SBDG -
Oral Tablet
317541DF -
Oral Product
1151131DFG - +1 more in this family
-
Selinexor Oral Tablet
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Selinexor 80 MG
2730151SCDC -
Selinexor 80 MG Oral Tablet [Xpovio]
2730154SBD -
Selinexor 80 MG [Xpovio]
2730153SBDC
-
Selinexor 80 MG
-
Packs 2
Fixed collections of drugs packaged and sold together, like dose packs.
Showing up to 8 concepts per family — 15 of 16 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
{4 (selinexor 80 MG Oral Tablet) } Pack
GPCK · 2730155 -
Selinexor 80 MG
SCDC · 2730151 -
Selinexor Oral Tablet
SCDF · 2178394 -
Selinexor Oral Product
SCDG · 2178392 -
Selinexor Pill
SCDG · 2178393
Brand-Name Concepts
-
Selinexor 80 MG Oral Tablet [Xpovio]
SBD · 2730154 -
{4 (selinexor 80 MG Oral Tablet [Xpovio]) } Pack [Xpovio 80 MG Once Weekly Carton-80 MG Tablet]
BPCK · 2730156 -
Selinexor 80 MG [Xpovio]
SBDC · 2730153 -
Selinexor Oral Tablet [Xpovio]
SBDF · 2178399 -
Xpovio Oral Product
SBDG · 2178400 -
Xpovio Pill
SBDG · 2178401 -
Xpovio
BN · 2178397
📦 FDA Products & Package NDCs
6 products · 9 package NDCs
9 package NDCs map to RxCUI 2730152 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 72237-0101-03 | 4 BLISTER PACK in 1 CARTON (72237-101-03) / 6 TABLET, FILM... | XPOVIO | Karyopharm Therapeutics Inc. | 2020-06-22 |
| 72237-0101-04 | 4 BLISTER PACK in 1 CARTON (72237-101-04) / 8 TABLET, FILM... | XPOVIO | Karyopharm Therapeutics Inc. | 2019-07-10 |
| 72237-0102-02 | 4 BLISTER PACK in 1 CARTON (72237-102-02) / 2 TABLET, FILM... | XPOVIO | Karyopharm Therapeutics Inc. | 2021-05-19 |
| 72237-0102-06 | 4 BLISTER PACK in 1 CARTON (72237-102-06) / 2 TABLET, FILM... | XPOVIO | Karyopharm Therapeutics Inc. | 2021-05-19 |
| 72237-0102-07 | 4 BLISTER PACK in 1 CARTON (72237-102-07) / 1 TABLET, FILM... | XPOVIO | Karyopharm Therapeutics Inc. | 2021-05-19 |
| 72237-0103-05 | 4 BLISTER PACK in 1 CARTON (72237-103-05) / 2 TABLET, FILM... | XPOVIO | Karyopharm Therapeutics Inc. | 2021-05-19 |
| 72237-0104-01 | 4 BLISTER PACK in 1 CARTON (72237-104-01) / 1 TABLET, FILM... | XPOVIO | Karyopharm Therapeutics Inc. | 2021-05-19 |
| 72237-0105-01 | 4 BLISTER PACK in 1 CARTON (72237-105-01) / 1 TABLET, FILM... | XPOVIO | Karyopharm Therapeutics Inc. | 2026-01-05 |
| 72237-0106-01 | 4 BLISTER PACK in 1 CARTON (72237-106-01) / 4 TABLET, FILM... | XPOVIO | Karyopharm Therapeutics Inc. | 2025-03-10 |
Observed labelers:
Karyopharm Therapeutics Inc. (9)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.